Literature DB >> 1833717

Identification and characterization of protein products of the cot oncogene with serine kinase activity.

M Aoki1, T Akiyama, J Miyoshi, K Toyoshima.   

Abstract

The products of the cot gene, a novel oncogene isolated by DNA transfection assay using the hamster cell line SHOK, were identified as 46 kDa and 52 kDa proteins by using anti-peptide antibodies. The 46 kDa and 52 kDa proteins both showed autophosphorylation activity at serine residues. The two forms of the Cot protein were suggested to differ in their amino-terminal structures as a result of alternative initiation of translation. Subcellular fractionation revealed that the 46 kDa and 52 kDa proteins are both predominantly localized in the cytosol. These Cot proteins are the fourth oncogene products with serine kinase activity identified.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833717

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  The COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity.

Authors:  Maria Luisa Gándara; Pilar López; Raquel Hernando; José G Castaño; Susana Alemany
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation.

Authors:  M Chiariello; M J Marinissen; J S Gutkind
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Cot/Tpl2 regulates IL-23 p19 expression in LPS-stimulated macrophages through ERK activation.

Authors:  K Kakimoto; T Musikacharoen; N Chiba; K Bandow; T Ohnishi; T Matsuguchi
Journal:  J Physiol Biochem       Date:  2010-04-20       Impact factor: 4.158

4.  Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.

Authors:  K L Decicco-Skinner; E L Trovato; J K Simmons; P K Lepage; J S Wiest
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

5.  Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity.

Authors:  Hong Seok Choi; Bong Seok Kang; Jung-Hyun Shim; Yong-Yeon Cho; Bu Young Choi; Ann M Bode; Zigang Dong
Journal:  FASEB J       Date:  2007-08-27       Impact factor: 5.191

6.  Mutational activation of the MAP3K8 protooncogene in lung cancer.

Authors:  Adam Michael Clark; Steven H Reynolds; Marshall Anderson; Jonathan S Wiest
Journal:  Genes Chromosomes Cancer       Date:  2004-10       Impact factor: 5.006

7.  Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis.

Authors:  Kathleen L Decicco-Skinner; Sarah A Jung; Tracy Tabib; J Curtis Gwilliam; Hepzibha Alexander; Sarah E Goodheart; Anand S Merchant; Mengge Shan; Caroline Garber; Jonathan S Wiest
Journal:  Carcinogenesis       Date:  2013-09-25       Impact factor: 4.944

8.  Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice.

Authors:  Kathleen L DeCicco-Skinner; Sabrina J Nolan; Monika M Deshpande; Erika L Trovato; Taylor A Dempsey; Jonathan S Wiest
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

9.  NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.

Authors:  F Sun; Z Qu; Y Xiao; J Zhou; T F Burns; L P Stabile; J M Siegfried; G Xiao
Journal:  Oncogene       Date:  2015-08-24       Impact factor: 9.867

10.  Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.

Authors:  Xinli Li; Chun Liu; Blanche C Ip; Kang-Quan Hu; Donald E Smith; Andrew S Greenberg; Xiang-Dong Wang
Journal:  J Exp Clin Cancer Res       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.